PMA P990040

Device
TRUFILL n-BCA Liquid Embolic System
Applicant
Cerenovus, Inc.
PMA number
P990040
Supplement
S029
Product code
KGG
Decision date
2026-10-23
Classification
Tissue Adhesive For Use In Embolization Of Brain Arteriovenous Malformations
Generic name
tissue adhesive for use in embolization of brain arteriovenous malformations
Approval order statement
Approval of the protocol for the TRUFILL post-approval study (PAS). The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P990040/S034.

Current openFDA PMA Record#

Device
TRUFILL n-BCA Liquid Embolic System
Applicant
Cerenovus, Inc.
PMA number
P990040
Supplement
S037
Product code
KGG
Generic name
tissue adhesive for use in embolization of brain arteriovenous malformations
Decision date
2026-10-23
Decision code
APPR
Date received
2026-02-02
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol
Approval order statement
Approval of the protocol for the TRUFILL post-approval study (PAS). The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P990040/S034.